BofA/Merrill Lynch Downgrades Spero Therapeutics (SPRO) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.04 -0.02 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.06 | 52 Week High | $3.85 | |||
| Open | $1.10 | 52 Week Low | $1.25 | |||
| Day High | $1.11 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $-0.28 | |||
| Volume | 433,564 | |||||
